RIO-Diabetes study Group. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. - Scheen,A.J.; Finer,N.; Hollander,P.; Jensen,M.D.; van Gaal,L.F. (Lancet, 2006)